The participant who triggered a global shutdown of AstraZenecas Phase 3 Covid-19 vaccine trials was a woman in the United Kingdom who experienced neurological symptoms consistent with a rare but seri… [+3908 chars]
AstraZeneca CEO says participant had neurological symptoms, could be discharged today – STAT
